These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 5453682

  • 41. [Treatment of pulmonary tuberculosis with intermittent dosage of streptomycin and isoniazid].
    Kisielewicz J, Fafrowicz B, Jablonowski Z, Kociecka I, Turczynowski R.
    Gruzlica; 1970; 38(7):719-22. PubMed ID: 5453681
    [No Abstract] [Full Text] [Related]

  • 42. Clinical experience after more than a year's ethambutol administration.
    Orlowski EH.
    Antibiot Chemother; 1970; 16():288-91. PubMed ID: 5523728
    [No Abstract] [Full Text] [Related]

  • 43. [Direct evaluation of the results of treatment of cutaneous tuberculosis with streptomycin, isoniazid and ethambutol].
    Arkuszewska C.
    Przegl Dermatol; 1980; 67(1):97-101. PubMed ID: 7375659
    [No Abstract] [Full Text] [Related]

  • 44. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC, Lee YC.
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [Abstract] [Full Text] [Related]

  • 45. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
    Szymański A, Walecki J, Czaplińska-Jóźwiak E, Kuczborska Z, Gaik A, Bilczak Z, Swiatnicka I, Swica T, Zdawski T.
    Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
    [No Abstract] [Full Text] [Related]

  • 46. [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
    Gómez Marín JE, Rigouts L, Villegas Londoño LE, Portaels F.
    Bol Oficina Sanit Panam; 1995 Jul; 119(1):1-10. PubMed ID: 7654295
    [Abstract] [Full Text] [Related]

  • 47. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G, Muñoz I, Ras R.
    Rev Tuberc Pneumol (Paris); 1970 Jul; 34(5):715-6. PubMed ID: 5496795
    [No Abstract] [Full Text] [Related]

  • 48. [Comparison of 2 intermittent therapeutic regimens: ethionamide-isoniazid and streptomycin-isoniazid].
    Lahlou M.
    Bull Int Union Tuberc; 1970 Jun; 43():289-94. PubMed ID: 5425557
    [No Abstract] [Full Text] [Related]

  • 49. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM, Belotserkovets VG.
    Probl Tuberk Bolezn Legk; 2004 Jun; (12):50-2. PubMed ID: 15719669
    [Abstract] [Full Text] [Related]

  • 50. Proceedings: Short course chemotherapy in pulmonary tuberculosis: a controlled trial by the British Thoracic and Tuberculosis Association. (A report from one of the three clinical co-ordinators).
    Somner AR.
    Tubercle; 1975 Jun; 56(2):165. PubMed ID: 1103397
    [No Abstract] [Full Text] [Related]

  • 51. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A, Rieder HL.
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract] [Full Text] [Related]

  • 52. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD, Kuppusamy I, Soshila R, Aziah AM, Faridza MY.
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [Abstract] [Full Text] [Related]

  • 53. [Combined streptomycin and isoniazid in high weekly doses in pulmonary tuberculosis].
    Magalhães M, Leal R, Menezes E, Walter N.
    Rev Bras Med; 1965 Oct; 22(10):648-9. PubMed ID: 5322480
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Biweekly treatment of pulmonary tuberculosis by isoniazid and streptomycin with or without initial continuous phase. Results obtained in Algeria].
    Larbaoui D, Abderrahim K.
    Rev Tuberc Pneumol (Paris); 1968 Nov; 32(7):939-48. PubMed ID: 5729100
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [On the use of ethambutol in venous perfusion associated with perfusions of PAS and INI in the treatment of pulmonary tuberculosis].
    Fossati C.
    G Ital Mal Torace; 1971 Nov; 25(1):31-6. PubMed ID: 5131786
    [No Abstract] [Full Text] [Related]

  • 58. [Concentration of streptomycin and isoniazid in the blood of patients over 50 with pulmonary tuberculosis after administration of the drugs in ultrasonic aerosols].
    Korablev VN.
    Antibiotiki; 1982 Dec; 27(12):53-6. PubMed ID: 7165296
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.